安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- ReAlta Life Sciences, Inc.
ReAlta Life Sciences, a clinical stage company focused on rare diseases, has developed a novel class of drugs with unique dual-targeting therapeutic capabilities that rebalance complement and inflammatory processes
- ReAlta Life Sciences Strengthens Board of Directors with Appointment of . . .
New appointments bring deep research and development expertise and technology innovation to support continued advancement of ReAlta’s EPICC Technology Platform
- ReAlta Life Sciences Strengthens Board of Directors with Appointment of . . .
Norfolk, VA – January 3, 2024 – ReAlta Life Sciences, Inc (“ReAlta” or the “Company”), a mid-stage clinical biotech company dedicated to saving lives by rebalancing the inflammatory response to address life-threatening diseases, today announced the appointment of three seasoned biotechnology executives, Christi Shaw, Mert Aktar
- ReAlta Life Sciences Announces New Inflammatory Biomarker Data from . . .
ReAlta’s therapeutic peptides employ the dual-targeting mechanisms of HAstV-1 to modulate both complement and innate inflammatory pathways by inhibiting complement cascade activation and two key neutrophil-driven mechanisms: myeloperoxidase (MPO) and neutrophil extracellular traps (NETs)
- Board of Directors - Realta Life Sciences
ReAlta Life Sciences is a clinical stage biotech company, dedicated to saving lives by rebalancing the inflammatory response through our EPICC technology platform
- About Us - Realta Life Sciences
ReAlta Life Sciences is a clinical stage biotech company, dedicated to saving lives by rebalancing the inflammatory response through our EPICC technology platform
- News about ReAlta Life Sciences
ReAlta Life Sciences Announces New Clinical Data for RLS-0071 (pegtarazimod) from Hypoxic Data confirm elevated inflammatory biomarkers in newborns with Hypoxic Ischemic Encephalopathy (HIE) and demonstrate a predictable pharmacokinetic profile for RLS-0071
- Management Team - Realta Life Sciences
ReAlta Life Sciences is a clinical stage biotech company, dedicated to saving lives by rebalancing the inflammatory response through our EPICC technology platform
|
|
|